Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04871672
Other study ID # Sponsor-Investigator:
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 26, 2021
Est. completion date February 23, 2023

Study information

Verified date October 2023
Source University of Jazan
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will be conducted in the Department of physical therapy, College of Applied Medical Sciences,Jazan University, to Effects of Pilates Exercises on core stability after Recovery from COVID - 19


Description:

145 male and female students who had infected with covid 19 with age 19 to 26 years old, will be recruited from the College of Applied Medical Sciences, Jazan University. Subjects will be randomly assigned to a pilates and home exercises (PAH) group or a control group who will perform only home exercises (COH) Four core endurance tests will be performed to assess the core stability Pilates exercise program will be composed of Pilates mat exercise program for a period of 12 weeks and three sessions every week. Each session took one hour. Every session started with 10 minutes of simple stretching movements to warm-up followed by the main part of the exercise plan for 40 min, followed by 10 minutes, some cool-down stretching. When the 12-week study period will over, the core stability will be assessed by the endurance tests and Prokin system for balance


Recruitment information / eligibility

Status Completed
Enrollment 145
Est. completion date February 23, 2023
Est. primary completion date October 24, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 19 Years to 26 Years
Eligibility Inclusion Criteria: 1. Persons who had mild to moderate covid- 19 illness. 2. Asymptomatic period of at least seven days (without chest pain, breathlessness). 3. No musculoskeletal damage. 4. No pregnancy. 5. No visually identified asymmetries in the spinal trunk and lower limbs. 6. None of the subjects has a history of balance training 7. Subjects will not have any diseases of the central nervous system. 8. Subjects with body mass index (BMI)<25 kg/m2. Exclusion Criteria: 1. Persons who had more severe covid 19 illnesses and were hospitalized. 2. Persons who had during their illness chest pain breathlessness, palpitation, symptoms, and signs of heart failure. 9. Subjects with cardiopulmonary disorders. 3. A history of previous back or abdominal surgery/injury 4. Evidence of a systemic or musculoskeletal disease within the past six months -

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Pilates Exercises
basic five pilates intermediate workout based on the principles of Pilates
Home Exercise program
home exercise

Locations

Country Name City State
Saudi Arabia Jazan University Riyadh Jazan

Sponsors (1)

Lead Sponsor Collaborator
University of Jazan

Country where clinical trial is conducted

Saudi Arabia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluation of core stability: endurance capacity of anterior deep trunk muscles Abdominal fatigue test: is an isometric trunk flexor test at the date of the first session and at the last session after 12 weeks
Primary Evaluation of core stability: assesses the functioning of trunk extensor muscles Sorensen back-extension endurance at the date of the first session and at the last session after 12 weeks
Primary Evaluation of core stability: Prone Plank test Prone Plank test at the date of the first session and at the last session after 12 weeks
Primary Evaluation of core stability: Endurance capacity of lateral core muscles particularly the quadrates lumborum Side Plank Tests at the date of the first session and at the last session after 12 weeks
Primary Evaluation of core stability: balance test by Prokin system for perimeter parameter with opened eyes, measured in mm Eyes Open perimeter (EOPM), measured in mm 30 seconds
Primary Evaluation of core stability: balance test by Prokin system for perimeter parameter with closed eyes, measured in mm Eyes closed perimeter (ECPM), measured in mm 30 seconds
Primary Evaluation of core stability: balance test by Prokin system for ellipse area parameter with Opened eyes, measured in mm Eyes Open ellipse area (EOEA) measured in mm2 30 seconds
Primary Evaluation of core stability: balance test by Prokin system for ellipse area parameter with closed eyes, measured in mm Eyes closed ellipse area (ECEA) measured in mm2 30 seconds
See also
  Status Clinical Trial Phase
Completed NCT05047692 - Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers Phase 1
Recruiting NCT04395768 - International ALLIANCE Study of Therapies to Prevent Progression of COVID-19 Phase 2
Terminated NCT04555096 - A Trial of GC4419 in Patients With Critical Illness Due to COVID-19 Phase 2
Completed NCT04508777 - COVID SAFE: COVID-19 Screening Assessment for Exposure
Completed NCT04506268 - COVID-19 SAFE Enrollment N/A
Completed NCT04961541 - Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine Phase 1/Phase 2
Active, not recruiting NCT04546737 - Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients N/A
Not yet recruiting NCT04543006 - Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19 N/A
Completed NCT04494646 - BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) Phase 2
Terminated NCT04581915 - PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19 Phase 2/Phase 3
Terminated NCT04542993 - Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy Phase 2
Completed NCT04532294 - Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants Phase 1
Completed NCT04387292 - Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Not yet recruiting NCT04527211 - Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel Phase 3
Completed NCT04537663 - Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults Phase 4
Completed NCT04979858 - Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask N/A
Not yet recruiting NCT05038449 - Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19 N/A
Completed NCT04610502 - Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients Phase 2
Active, not recruiting NCT06042855 - ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) Phase 3